Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Pinatuzumab Vedotin|
Pinatuzumab Vedotin (DCDT2980S) is an antibody drug conjugate (ADC) comprising a monoclonal antibody against CD22 attached to the drug monomethyl auristatin E, potentially resulting in increased death of CD22-positive tumor cells (PMID: 25708834, PMID: 30935953).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Obinutuzumab + Pinatuzumab Vedotin + Rituximab||Obinutuzumab Pinatuzumab Vedotin Rituximab||0||1|
|Pinatuzumab Vedotin||Pinatuzumab Vedotin||0||0|
|Pinatuzumab Vedotin + Polatuzumab vedotin-piiq + Rituximab||Pinatuzumab Vedotin Polatuzumab vedotin-piiq Rituximab||0||1|